Published: Guidance, quality standards and advice
Showing 1 to 3 of 3
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Cetuximab and panitumumab for previously untreated metastatic colorectal cancer | TA439 | ||
| Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) | TA240 | ||
| Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy | TA242 |